David M Angaran

David M Angaran,

Affiliate Faculty

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-6231
Business Email: angaran@ufl.edu

Teaching Profile

Courses Taught
2014
PHA5933 Select Top Pharmacy
2013
PHA6291 Pharmaceutical Health Care Systems
2009
PHA5783 Pharmacotherapy 3

Publications

2020
Opportunities and responsibilities for pharmacists to improve their effectiveness in addressing medication adherence through culturally sensitive collaborations with community health workers.
Journal of the American Pharmacists Association : JAPhA. 60(4):e25-e30 [DOI] 10.1016/j.japh.2020.02.023. [PMID] 32217086.
2012
Near misses and incidents.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 69(3):256-8 [DOI] 10.2146/ajhp110293. [PMID] 22261950.
2007
Full disclosure.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 64(12):1331-3 [PMID] 17563057.
2005
Benzodiazepines and injury: a risk adjusted model.
Pharmacoepidemiology and drug safety. 14(1):17-24 [PMID] 15386711.
2000
Clinical pharmacy: looking 20 years back… looking 20 years forward.
Pharmacotherapy. 20(10 Pt 2):235S-242S [PMID] 11034049.
1999
Clinical pharmacy saves money and lives–so what’s new?
Pharmacotherapy. 19(12):1352-3 [PMID] 10600082.
1999
Telemedicine and telepharmacy: current status and future implications.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 56(14):1405-26 [PMID] 10428449.
1997
Retiree health care: a new model for improving health and reducing costs.
Employee benefits journal. 22(2):2-4 [PMID] 10168419.
1992
Evolving role of the pharmacist in critical care.
Critical care medicine. 20(5):563-5 [PMID] 1572179.
1991
Quality assurance to quality improvement: measuring and monitoring pharmaceutical care.
American journal of hospital pharmacy. 48(9):1901-7 [PMID] 1928130.
1991
Selecting, developing, and evaluating indicators.
American journal of hospital pharmacy. 48(9):1931-7 [PMID] 1928135.
1991
The effects of hemodilution, pH, and protamine on lidocaine plasma protein binding and red blood-cell uptake in vitro.
Pharmaceutical research. 8(1):127-30 [PMID] 1901648.
1990
Measuring and monitoring health care.
Topics in hospital pharmacy management. 10(2):1-11 [PMID] 10128559.
1990
Oxygen homeostasis: theory, measurement, and therapeutic implications.
DICP : the annals of pharmacotherapy. 24(12):1195-203 [PMID] 2089832.
1989
Measuring and monitoring the quality of healthcare.
Current concepts in hospital pharmacy management. 11(2):4-5, 18 [PMID] 10293151.
1988
Career patterns of pioneer clinical pharmacists.
American journal of hospital pharmacy. 45(1):101-8 [PMID] 3348221.
1988
Status of injectable calcium antagonists.
Clinical pharmacy. 7(7) [PMID] 3416571.
1987
Pharmacologic and pharmacokinetic comparison of antianginal agents.
Pharmacotherapy. 7(5 Pt 2):62S-71S [PMID] 3324060.
1987
The comparative influence of prophylactic antibiotics on the prothrombin response to warfarin in the postoperative prosthetic cardiac valve patient. Cefamandole, cefazolin, vancomycin.
Annals of surgery. 206(2):155-61 [PMID] 3300580.
1986
Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
Clinical pharmacy. 5(4):288-303 [PMID] 2871961.
1986
Proceedings of a symposium on careers in clinical pharmacy. Patterns among the pioneers.
American journal of hospital pharmacy. 43(11):2747-50 [PMID] 3799606.
1984
Colloids vs. crystalloids–a continuing controversy.
Drug intelligence & clinical pharmacy. 18(3):202-12 [PMID] 6199175.
1984
The influence of prophylactic antibiotics on the warfarin anticoagulation response in the postoperative prosthetic cardiac valve patient. Cefamandole versus vancomycin.
Annals of surgery. 199(1):107-11 [PMID] 6691723.
1983
Middle manager: assistant director for clinical services.
Topics in hospital pharmacy management. 3(2):76-9 [PMID] 10314025.
1983
Volume of infusion controller and delayed vasopressor effect.
Annals of internal medicine. 99(3):415-6 [PMID] 6614706.
1982
Effect of sodium nitroprusside during the payback period of cardiopulmonary bypass on the incidence of postoperative arrhythmias.
The Annals of thoracic surgery. 34(3):307-12 [PMID] 7052000.
1982
Intermittent intravenous potassium therapy in cardiopulmonary bypass patients.
Clinical pharmacy. 1(3):234-8 [PMID] 7185519.
1980
Use of Clinitest urine test for indirect estimation of blood glucose levels in the critically ill.
American journal of hospital pharmacy. 37(7):950-6 [PMID] 7395888.
1978
Cephalosporin-clinitest interaction: comparison of cephalothin, cefazolin and cephradine.
American journal of hospital pharmacy. 35(9):1064-7 [PMID] 696749.
1978
Johnny can’t read.
Drug intelligence & clinical pharmacy. 12(8) [PMID] 10237345.
1977
Hazards of mechanical ventilation–therapeutic implications.
American journal of hospital pharmacy. 34(4):362-6 [PMID] 324275.
1976
A communication from Dr. Clinical: The Cynic Commission.
Drug intelligence & clinical pharmacy. 10(7):394-5 [PMID] 10236253.
1975
A response to Dr. Knapp’s presentation: “Coordinating and Optimizing Educational Efforts between Basic Science Faculty and Clinical Faculty: Pharmacy Administration”.
American journal of pharmaceutical education. 39(5) [PMID] 10237163.
1975
A white coat, name tag and beeper.
Drug intelligence & clinical pharmacy. 9(10):566-7 [PMID] 10237347.
1975
Flow charts as adjuncts to symptomatic screening.
Journal of the American Pharmaceutical Association. 15(4):193-7 [PMID] 1127209.
1975
My son, the clinical pharmacist.
Drug intelligence & clinical pharmacy. 9(6):298-9 [PMID] 10236935.
1975
Strategy for clinical pharmacy in hard times.
Drug intelligence & clinical pharmacy. 9(4) [PMID] 10236931.

Contact Details

Phones:
Business:
(352) 273-6231
Emails:
Business:
angaran@ufl.edu
Addresses:
Business Mailing:
PO Box 100486
GAINESVILLE FL 32610
Business Street:
101 SOUTH NEWELL DR, HPNP RM 3306
GAINESVILLE FL 32611